J2472 Pantoprazole 40mg HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS J2472: Pantoprazole Sodium 40 mg Injection

HCPCS Level II code J2472 denotes a 40 mg injection of pantoprazole sodium in sodium chloride (Baxter), an intravenous proton pump inhibitor formulation used to suppress gastric acid. This drug administration code matters nationally because IV pantoprazole is commonly used in hospital settings for acute gastrointestinal bleeding, perioperative acid suppression, and when oral therapy is not feasible. Accurate coding of J2472 influences facility payment, inventory tracking, and clinical documentation for inpatient and outpatient infusion services.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical sites of service, and the clinical context for IV pantoprazole use. The publication also outlines billing considerations and benchmarks where available, summarizes relevant policy updates and payer coverage patterns when present, and highlights areas where additional documentation or coding precision can affect reimbursement and claims processing. Data not available in the input will be identified as such.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ2472HCPCS Level IIpantoprazoleintravenous medicationinfusionhospital billingdrug administrationpharmacyfacility coding

Billing Code Overview

HCPCS Level II code J2472 describes an injection of pantoprazole sodium in sodium chloride (Baxter), 40 mg. This code represents a single-dose intravenous formulation of pantoprazole, a proton pump inhibitor used to reduce gastric acid secretion.

Service type: Intravenous injection/infusion medication administration
Typical site of service: Hospital inpatient or outpatient infusion setting, emergency department, or other facility-based intravenous medication administration areas

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 62-year-old hospitalized patient with a history of gastroesophageal reflux disease (GERD) and recent upper gastrointestinal bleeding is admitted for stabilization and intravenous acid suppression. The patient is NPO for scheduled endoscopy and requires parenteral proton pump inhibitor therapy. A clinician orders J2472 — Injection, pantoprazole sodium in sodium chloride (Baxter), 40 mg — to be administered intravenously via peripheral or central line. Nursing verifies allergies, obtains baseline vital signs, and prepares the medication per manufacturer directions. The medication is typically given as a bolus over several minutes or as an intermittent infusion; dosing frequency is documented in the MAR. The workflow includes medication administration record entry, unit dose or pharmacy dispense documentation, and billing with the HCPCS code J2472. If the patient undergoes endoscopy, the IV pantoprazole may be continued post-procedure for ulcer stabilization. Typical sites of service are inpatient hospital (acute care), observation, emergency department, and ambulatory infusion center for patients requiring IV therapy. Common clinical roles involved are hospitalists, gastroenterologists, emergency physicians, registered nurses, and infusion pharmacists.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier (default)

HCPCS Level II J0578: Buprenorphine Extended-Release Injection, 7–28 Days

HCPCS-J0693-CEFIDEROCOL-INJECTION-5MG

HCPCS J0693: Injection, Cefiderocol, 5 mg

HCPCS-J1380-ESTRADIOL-VALERATE-INJECTION-UP-TO-10-MG

HCPCS Level II J1380: Injection, Estradiol Valerate, up to 10 mg

HCPCS-J1575-IMMUNE-GLOBULIN-HYALURONIDASE-HYQVIA-SUBCUTANEOUS-INFUSION

HCPCS J1575: Immune Globulin with Hyaluronidase (HyQvia), 100 mg

HCPCS-J3070-PENTAZOCINE-INJECTION-30MG

HCPCS J3070: Injection, Pentazocine 30 mg

HCPCS-J3304-TRIAMCINOLONE-EXTENDED-RELEASE-INJECTION-1MG

HCPCS J3304: Triamcinolone Acetonide Extended-Release Injection, 1 mg

HCPCS-J1050-MEDROXYPROGESTERONE-ACETATE-INJECTION-1MG

HCPCS J1050: Medroxyprogesterone acetate injection, 1 mg

HCPCS-J0456-AZITHROMYCIN-500MG-INJECTION

HCPCS Level II J0456: Azithromycin 500 mg Injection

HCPCS-J0874-DAPTOMYCIN-INJECTION-BAXTER-1MG

HCPCS J0874: Daptomycin (Baxter) Injection, 1 mg

HCPCS-J2250-MIDAZOLAM-INJECTION-1MG

HCPCS J2250: Injection, Midazolam Hydrochloride, per 1 mg

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`207RH0000X`	Hospitalist	Hospitalists frequently order and manage IV pantoprazole for inpatients.
`207RG0102X`	Gastroenterology	Gastroenterologists manage upper GI bleeding, GERD, and prescribe IV PPI therapy.
`208D00000X`	Emergency Medicine	Emergency physicians commonly initiate IV pantoprazole in the ED for GI bleeding or severe reflux.
`163W00000X`	Clinical Nurse Specialist	Advanced practice nurses may administer or oversee infusion therapy.
`363L00000X`	Pharmacist	Infusion pharmacists prepare and verify parenteral pantoprazole formulations.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`K25.4`	Chronic or unspecified gastric ulcer, with hemorrhage	IV pantoprazole is used to reduce gastric acid and promote hemostasis in bleeding peptic ulcers.
`K92.2`	Gastrointestinal hemorrhage, unspecified	Empiric indication for IV proton pump inhibitor therapy while source is evaluated.
`K21.9`	Gastro-esophageal reflux disease without esophagitis	Severe GERD requiring short-term IV therapy when oral route unavailable.
`I85.01`	Esophageal varices with bleeding	Acid suppression may be part of supportive care in upper GI bleeding; primary variceal therapy targets bleeding source.
`K29.7`	Gastroenteritis and colitis, unspecified	In select severe cases with bleeding or intolerant oral intake, IV PPI may be used as part of supportive care.
`R10.0`	Acute abdomen	When GI bleeding or peptic ulcer disease is suspected in acute abdomen, IV pantoprazole may be administered pending diagnosis.
`Z45.018`	Encounter for adjustment and management of other implanted infusion device	Relevant if IV access or infusion devices are managed for ongoing parenteral therapy including pantoprazole.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	May be used when pantoprazole is administered as an infusion that meets the time criteria for initial therapeutic infusion billing.
`96366`	Intravenous infusion, each additional hour (List separately in addition to code for primary infusion)	Use when pantoprazole infusion continues beyond the first hour and payer allows hour-based infusion billing.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Not typically used for IV pantoprazole but may be billed for injections by route when payer requires; verify route and policy.
`43239`	Esophagogastroduodenoscopy, flexible, transoral; with control of bleeding, any method	Often performed in workup of upper GI bleeding where IV pantoprazole `J2472` is administered before, during, or after the procedure.
`45385`	Colonoscopy with control of bleeding	In cases of lower GI bleeding where IV PPI may be part of stabilization, this procedure may occur in the same clinical encounter.
`96374`	Intravenous push, each additional substance/drug	Use when pantoprazole is administered as an IV push in conjunction with other push medications and payer supports separate reporting.

OpenPayer